Advertisement

On the Influence of Plasma Kallikrein Inhibitors and Antihistaminics on Formalin Edema of the Rat Paw (Prepared Discussion Remark)

  • E. Werle
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 8)

Abstract

It was already shown by H. Kaller that the development of the rat paw edema eliceted by different kinds of inflammatory drugs is inhibited to some degree by Trasylol. Trasylol is known to inhibit many proteinases including plasma kallikrein. It is thought that in the course of the events which lead to the edema, plasma kallikrein is activated which in turn liberates bradykinin. Thus the inhibiting effect of Trasylol in the development of edema seems to be due to the inhibition of plasma kallikrein. We checked if thioglycolic acid which destroys plasma kallikrein rapidly, also inhibits the edema development. We studied this in the formalin edema of the rats paw. Formalin was injected deep in the paw. Simultanously inhibitors of plasma kallikrein, f.i. Trasylol intra peritoneally. The inhibiting effect of different amounts of Trasylol is shown on Fig.1, that of thioglycolic acid on Fig. 2.

Keywords

Mast Cell Clinical Biochemistry Thioglycolic Acid Inflammatory Drug Plasma Kallikrein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. van Arman, C.G., G.W. Nuss, C.A. Winter and L. Flataker: Proc. 3rd Int.Pharmacol.Meeting Sao Paulo 1966, Pergamon Press 1968, Vol. 9, p. 25.Google Scholar
  2. Kaller, K.: in: Neue Aspekte der Trasylol-Therapie, F.K. Schattauer-Verlag Stuttgart 1965, p. 152.Google Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • E. Werle
    • 1
  1. 1.Institute of Clinical Chemistry and Clinical BiochemistryUniversity of MunichGermany

Personalised recommendations